Johnson & Johnson Expands Wilson County, North Carolina, Production Operations
01/16/2026
The company’s new manufacturing facility will produce medicines for oncology and neurological diseases.
“We are pleased to make another significant manufacturing investment in North Carolina. This new facility is the third North Carolina project announced by Johnson & Johnson in the past year and will help to further accelerate the delivery of our portfolio of transformational medicines for patients,” said Jennifer Taubert, Executive Vice President, Worldwide Chairman, Innovative Medicine, Johnson & Johnson. “North Carolina is an important life sciences hub, and we look forward to increasing our presence in the state.”
The project will be supported by an expected legislative appropriation of $12 million to expand the training center at Wilson Community College. A grant from the state’s Industrial Development Fund – Utility Account is also expected.
“North Carolina has one of the largest life sciences workforces in the nation,” noted N.C. Commerce Secretary Lee Lilley. “Economic and workforce development collaboration is critical to ensuring we have the foundation and business climate for innovators like Johnson &Johnson to succeed, and we remain laser-focused on maintaining and strengthening our leadership in the life sciences.”
Partnering with the North Carolina Department of Commerce and the Economic Development Partnership of North Carolina on the project were the North Carolina General Assembly, the North Carolina Biotechnology Center, the North Carolina Community College System, the North Carolina Department of Environmental Quality, Wilson Community College, the BioPharma Crescent, Wilson County, the Wilson Economic Development Council, and the City of Wilson.
“Johnson & Johnson’s decision to continue investing in North Carolina is a strong vote of confidence in our state and in the stellar workforce that powers our life sciences economy,” added Christopher Chung, CEO of the Economic Development Partnership of North Carolina. “The company has long been a valued partner here, and this investment reinforces both North Carolina’s leadership in life sciences and Wilson County’s emergence as a growing hub for high-quality jobs.”
“J&J has quickly integrated into our NC life sciences community, and we are grateful for the opportunity to support another facet of their operations in the state,” said Laura Rowley, Ph.D., vice president of life sciences economic development at the North Carolina Biotechnology Center. “The commitment from the General Assembly to strengthen and expand the training network in Eastern North Carolina is not only an investment to ensure J&J’s success but will seed future life sciences growth in the region.”
Project Announcements
Blevins Asphalt Expands Mount Vernon, Missouri, Maintenance Operations
04/28/2026
Niagara Bottling Plans Perth, New York, Production-Warehouse Operations
04/26/2026
Marubeni-Itochu Steel America Plans Osceola, Arkansas, Flat-Rolled Steel Operations
04/25/2026
Corderill Plans Meridian, Mississippi, Operations
04/25/2026
Ferrara Candy Plans Orangeburg County, South Carolina, Production Operations
04/25/2026
Blue Ops Plans Valdosta, Georgia, Manufacturing Operations
04/25/2026
Most Read
-
Economic Developer Role Shifting from Deal-Making to Systems Stewardship
Q1 2026
-
What Companies Need from Modern Manufacturing Sites
Q1 2026
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Capitalizing on the OBBBA Before the 2026 Cliff
Q1 2026
-
40th Annual Corporate and 22nd Annual Consultant Site Selection Survey Results
Q1 2026
-
Where Workforce Capacity Is Being Built — and Where It’s Being Deployed
Q1 2026
-
Last Word: Don’t Lose by Winning
Q1 2026